The cost of treating patients with COPD in Denmark--a population study of COPD patients compared with non-COPD controls.

[1]  I. Durand-zaleski,et al.  The SCOPE study: health-care consumption related to patients with chronic obstructive pulmonary disease in France. , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[2]  N. Keiding,et al.  Women's death in Scandinavia — what makes Denmark different? , 2003, European Journal of Epidemiology.

[3]  J. Vestbo,et al.  [Chronic obstructive pulmonary disease. Admission, course and prognosis]. , 2003, Ugeskrift for laeger.

[4]  R. Dahl,et al.  The economic impact of COPD in North America and Europe. Analysis of the Confronting COPD survey. Introduction. , 2003, Respiratory medicine.

[5]  E. Wouters.  Economic analysis of the Confronting COPD survey: an overview of results. , 2003, Respiratory medicine.

[6]  M. Faulkner,et al.  The economic impact of chronic obstructive pulmonary disease , 2002, Expert opinion on pharmacotherapy.

[7]  J. Clouse,et al.  Implications of controlling for comorbid conditions in cost-of-illness estimates: a case study of osteoarthritis from a managed care system perspective. , 2001, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[8]  A. Gulsvik,et al.  The global burden and impact of chronic obstructive pulmonary disease worldwide. , 2001, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[9]  S. Ramsey,et al.  The economic burden of COPD. , 2000, Chest.

[10]  G. Diette,et al.  Capitation, managed care, and chronic obstructive pulmonary disease. , 1998, American journal of respiratory and critical care medicine.

[11]  J. Vestbo,et al.  Life expectancy in Danish women and men related to smoking habits: smoking may affect women more. , 1998, Journal of epidemiology and community health.

[12]  J. Vestbo,et al.  Mortality in women and men in relation to smoking. , 1998, International journal of epidemiology.

[13]  R H Brook,et al.  Costs attributable to osteoarthritis. , 1998, The Journal of rheumatology.

[14]  Denmark,et al.  Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study , 2002 .

[15]  S. Gabriel,et al.  Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls. , 1997, The Journal of rheumatology.

[16]  S. Gabriel,et al.  Costs of osteoarthritis: estimates from a geographically defined population. , 1995, The Journal of rheumatology. Supplement.